Epidemiology of cervical cancer with special focus on India

A Sreedevi, R Javed, A Dinesh - International journal of women's …, 2015 - Taylor & Francis
Cervical cancer is on the declining trend in India according to the population-based
registries; yet it continues to be a major public health problem for women in India …

Portfolio theory: as I still see it

HM Markowitz - Annu. Rev. Financ. Econ., 2010 - annualreviews.org
This essay summarizes my views on (a) the foundations of portfolio theory and its
applications to current issues, such as the choice of criteria for practical risk-return analysis …

[HTML][HTML] Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)

LE Markowitz, EF Dunne, M Saraiya, HW Chesson… - MMWR Recomm …, 2014 - cdc.gov
This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

ML Gillison, WM Koch, RB Capone… - Journal of the …, 2000 - academic.oup.com
Background: High-risk human papillomaviruses (HPVs) are etiologic agents for anogenital
tract cancers and have been detected in head and neck squamous cell carcinomas …

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective

FX Bosch, MM Manos, N Muñoz… - JNCI: Journal of the …, 1995 - academic.oup.com
Background Epidemiologic studies have shown that the association of genital human
papillomavirus (HPV) with cervical cancer is strong, independent of other risk factors, and …

Natural history of cervicovaginal papillomavirus infection in young women

GYF Ho, R Bierman, L Beardsley… - New England Journal …, 1998 - Mass Medical Soc
Background Genital human papillomavirus (HPV) infection is highly prevalent in sexually
active young women. However, precise risk factors for HPV infection and its incidence and …

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of …

CM Wheeler, X Castellsagué, SM Garland… - The lancet …, 2012 - thelancet.com
Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-
adjuvanted vaccine against non-vaccine oncogenic HPV types in the end-of-study analysis …

The epidemiology of human papillomavirus infections

JG Baseman, LA Koutsky - Journal of clinical virology, 2005 - Elsevier
Infection with oncogenic human papillomavirus (HPV) types is a necessary cause of cervical
cancer, the second most frequently occurring cancer in women worldwide. Rates of …

Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study

N Muñoz, S Franceschi, C Bosetti, V Moreno, R Herrero… - The Lancet, 2002 - thelancet.com
Background High parity has long been suspected of being associated with an increased risk
of cervical cancer, but previous analyses of this association have not taken the strong effect …

Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study

V Moreno, FX Bosch, N Muñoz, CJLM Meijer, KV Shah… - The Lancet, 2002 - thelancet.com
Background Use of oral contraceptives could increase risk of cervical cancer; however the
effect of human papillomavirus (HPV), the main cause of cervical cancer, is not usually taken …